AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Genentech ocrevus copay assistance12/11/2023 “Cosentyx is the first and only fully human IL-17A antagonist which has demonstrated efficacy in moderate to severe plaque psoriasis, which may involve troublesome areas such as the nails, the scalp, hands and feet,” he says. In the summer months, this is especially important because clothing worn in warmer weather tends to expose more skin and therefore more unsightly plaque.įabrice Chouraqui, president of Novartis Pharmaceuticals Corp., says the treatment of psoriasis has been evolving over the years and there are now multiple therapeutic options. Patients are often faced with embarrassment because of the visible plaques on their skin and some patients isolate themselves for fear that others will think their disease is contagious. Psoriasis is a common autoimmune disease that affects more than 8 million people in the United States and has a significant burden on patients’ quality of life. Here are some of the latest advancements for autoimmune disease diagnoses and treatments. “We are very fortunate to live in an era where the therapies to treat many autoimmune diseases are highly effective, especially if they are prescribed early.” If autoimmune diseases are allowed to progress without any therapeutic intervention, irreversible tissue damage and disability ensue,” he says. Receiving an accurate diagnosis as quickly as possible is vital to ensure for the best long-term outcomes. He adds that all too often, patients are wandering through the healthcare system trying to find answers and some patients receive the wrong diagnosis and are placed on medicines that are not only expensive but also carry a high level of risk. Science and technology have drastically improved how autoimmune diseases are managed, and there are more options than ever before to treat autoimmune diseases.Ĭhase Spurlock, PhD, professor at Vanderbilt University and CEO of IQuity, a Nashville-based analytics startup offering an autoimmune disease-focused data analytics platform, says for many autoimmune diseases the available treatments can effectively control disease, but there is no one-size-fits-all approach.
0 Comments
Read More
Leave a Reply. |